Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emmanouela Zoulia"'
Autor:
Elli Papaemmanuil, George Vrachiolias, Zoi Bezirgiannidou, Menelaos Papoutselis, Elsa Bernard, Emmanouela Zoulia, Eleftheria Lamprianidou, Chryssoula Kordella, Ioannis Kotsianidis
Publikováno v:
Leukemia & Lymphoma. 60:3277-3281
Azacytidine (AZA) remains the mainstay of therapy for patients with high-risk Myelodysplastic syndrome (HR-MDS). The antineoplastic effects of AZA are thought to be mediated by two core mechanisms,...
Autor:
Lydia Kalafati, Panayiotis Garantziotis, Eleftheria Lamprianidou, Ioannis Kotsianidis, Chryssoula Kordella, Athanasios Galanopoulos, Nora Viniou, Stamatia Laidou, Elsa Bernard, Ioannis Mitroulis, Anastasia Chatzidimitriou, Emmanouela Zoulia, Vassiliki Pappa, Anastasiya Kazachenka, Theodoros P. Vassilakopoulos, George Kassiotis, Anastasia Filia, Elli Papaemmanuil, Evangelia Nakou, Sotirios G. Papageorgiou
Publikováno v:
Blood Adv
CD4+ T cells orchestrate immune responses and are actively engaged in shaping tumor immunity. Signal transducer and activator of transcription (STAT) signaling controls the epigenetic tuning of CD4+ T-cell differentiation and polarization, and pertur
Autor:
Evangelia Nakou, Ioannis Kotsianidis, Athina Vasilaki, Eleftheria Lamprianidou, Michail Daniilidis, Antonios Gerofotis, George Pantos, Emmanouela Zoulia, Chryssoula Kordella
Publikováno v:
Clinical Immunology. 210:108261
Foxp3+ T regulatory cell (Tregs) are central in the pathobiology of recurrent spontaneous abortions (RSA). Signal transducer and activator of transcription (STAT) proteins instruct Treg differentiation and polarization, but the STAT signaling archite
Autor:
Theodoros P. Vassilakopoulos, Evangelia Nakou, Chrysoula Kordella, Stamatia Laidou, Anastasia Hadzidimitriou, Anastasiya Kazachenka, Elli Papaemmanuil, Elsa Bernard, Ioannis Kotsianidis, George Kassiotis, Sotirios G. Papageorgiou, Emmanouela Zoulia, Eleftheria Lamprianidou, Athanasios Galanopoulos, Ioannis Mitroulis, Vassiliki Pappa, Anastasia Filia, Nora-Athina Viniou
Publikováno v:
Blood. 134:2988-2988
Azacytidine (AZA), the mainstay of therapy in high risk Myelodysplastic syndromes (HR-MDS), affects CD4+ T-cell polarization and function, but the effect of these changes on tumor immunity is unclear. Signal transducer and activator of transcription
Autor:
Chrysoula Kordella, Ioannis Kotsianidis, Eleftheria Lamprianidou, Anastasiya Kazachenka, Urszula Eksmond, Emmanouela Zoulia, George Vrachiolias, George Kassiotis, Menelaos Papoutselis, Zoe Bezirgiannidou, Emmanouil Spanoudakis, Christiana Georgiou
Publikováno v:
Blood. 132:4349-4349
Hypomethylating agents (HMA) such as azacytidine and decitabine are the mainstay of treatment for higher risk myelodysplastic syndromes (MDS) and are also used to treat older, unfit patients with acute myeloid leukemia (AML). Being cytidine analogues